Published in J Clin Microbiol on November 01, 1984
Safety of refrigerated storage of admixed parenteral fluids. J Clin Microbiol (1988) 0.75
Antibiotic susceptibility testing by a standardized single disk method. Am J Clin Pathol (1966) 159.00
Outbreak of hospital infection caused by contaminated autoclaved fluids. Lancet (1972) 6.85
Infection control in intravenous therapy. Ann Intern Med (1973) 3.59
Standardization of the Analytab Enteric (API 20E) system to increase accuracy and reproducibility of the test for biotype characterization of bacteria. J Clin Microbiol (1978) 2.11
Septicemia from intravenous infusions. N Engl J Med (1971) 1.96
Nationwide epidemic of septicemia caused by contaminated infusion products. IV. Growth of microbial pathogens in fluids for intravenous infusions. J Infect Dis (1975) 1.43
Upper respiratory tract carriage of gram-negative enteric bacilli by hospital personnel. JAMA (1970) 1.34
Nationwide epidemic of septicemia caused by contaminated intravenous products: mechanisms of intrinsic contamination. J Clin Microbiol (1975) 1.22
Hand carriage of aerobic Gram-negative rods by health care personnel. J Hyg (Lond) (1982) 0.98
Klebsiella pneumoniae nosocomial epidemic in an intensive care nursery due to contaminated intravenous fluid. Am J Dis Child (1977) 0.96
Airborne drug levels in a laminar-flow hood. Am J Hosp Pharm (1981) 0.90
Intraluminal antibiotic treatment of central venous catheter infections in patients receiving parenteral nutrition at home. Clin Infect Dis (1995) 2.36
Nosocomial Legionnaires' disease caused by aerosolized tap water from respiratory devices. J Infect Dis (1982) 1.81
Isolation and characterization of a seventh serogroup of Legionella pneumophila. J Clin Microbiol (1983) 1.66
Brucellosis in a group of travelers to Spain. JAMA (1984) 1.63
Performance measurement in pneumonia care: beyond report cards. Mayo Clin Proc (1998) 1.45
Growth of the human optic disk and nerve during gestation, childhood, and early adulthood. Am J Ophthalmol (1993) 1.44
An outbreak of bloodstream infections arising from hemodialysis equipment. J Infect Dis (1998) 1.42
Detection of soluble Legionella pneumophila antigens in serum and urine specimens by enzyme-linked immunosorbent assay with monoclonal and polyclonal antibodies. J Clin Microbiol (1984) 1.40
Relationships between inhibition constants and fractional inhibition in enzyme-catalyzed reactions with different numbers of reactants, different reaction mechanisms, and different types and mechanisms of inhibition. Mol Pharmacol (1974) 1.37
Pumonary aspergillosis during hospital renovation. Am Rev Respir Dis (1978) 1.28
Invasive aspergillosis in liver transplant recipients in the 1990s. Transplantation (1997) 1.23
False-positive blood cultures. Association with nonsterile blood collection tubes. JAMA (1976) 1.18
Prevalence and significance of Legionella pneumophila contamination of residential hot-tap water systems. J Infect Dis (1985) 1.14
'Golden tongue' syndrome caused by Ramichloridium schulzeri. Arch Dermatol (1985) 1.06
An outbreak of gram-negative bacteremia traced to contaminated O-rings in reprocessed dialyzers. Ann Intern Med (1993) 1.05
Malassezia furfur catheter infection cured with antibiotic lock therapy. Am J Med (1991) 1.05
Early detection of hypersensitivity pneumonitis in office workers. Am J Med (1978) 1.02
Outbreak of JK diphtheroid infections associated with environmental contamination. J Clin Microbiol (1984) 1.01
Generation from tumor-bearing mice of lymphocytes with in vivo therapeutic efficacy. J Immunol (1987) 1.01
Perirectal abscess caused by Legionella pneumophila and mixed anaerobic bacteria. Ann Intern Med (1983) 1.00
Bacterial infection as a complication of liver transplantation: epidemiology and risk factors. Rev Infect Dis (1991) 0.99
Lymphocytes generated by in vivo priming and in vitro sensitization demonstrate therapeutic efficacy against a murine tumor that lacks apparent immunogenicity. J Immunol (1989) 0.98
Beneficial effects of penicillamine treatment on hereditary avian muscular dystrophy. J Clin Invest (1975) 0.98
The incidence of and clinical variables associated with vancomycin-resistant enterococcal colonization in mechanically ventilated patients. Chest (1999) 0.96
Pseudomonas fluorescens bacteremia from blood transfusion. Am J Med (1984) 0.94
Cefepime versus ceftazidime as empiric therapy for fever in neutropenic patients with cancer. Ann Pharmacother (2000) 0.91
Long-term effect of xylitol gum use on mutans streptococci in adults. Caries Res (2007) 0.90
Epidemic measles in Chicago in 1983. Sustained transmission in the preschool population. Am J Dis Child (1986) 0.89
Adoptive immunotherapy of a syngeneic murine leukemia with a tumor-specific cytotoxic T cell clone and recombinant human interleukin 2: correlation with clonal IL 2 receptor expression. J Immunol (1986) 0.89
Timing of postoperative adjustment in adjustable suture strabismus surgery. J AAPOS (2001) 0.88
In vitro sensitization and expansion with viable tumor cells and interleukin 2 in the generation of specific therapeutic effector cells. J Immunol (1986) 0.88
Patterns of infection after pediatric liver transplantation. Am J Dis Child (1992) 0.87
Cellular interactions and the role of interleukin 2 in the expression and induction of immunity against a syngeneic murine sarcoma. J Immunol (1987) 0.86
Incidence and outcome of infection by vancomycin-resistant Enterococcus following orthotopic liver transplantation. Transplantation (1998) 0.86
Antigenic and genetic variation in Legionella pneumophila serogroup 6. J Clin Microbiol (1989) 0.86
Stochastic self-assembly of incommensurate clusters. J Chem Phys (2012) 0.85
Differences in the effects of host suppression on the adoptive immunotherapy of subcutaneous and visceral tumors. Cancer Res (1986) 0.85
In vitro differentiation of T-cells capable of mediating the regression of established syngeneic tumors in mice. Cancer Res (1987) 0.83
Safety of peripheral intravenous catheters in children. Infect Control Hosp Epidemiol (1999) 0.82
Cellular basis of immunologic interactions in adoptive T cell therapy of established metastases from a syngeneic murine sarcoma. J Immunol (1988) 0.82
Multiple myeloma-associated systemic vasculopathy due to crystalglobulin or polyarteritis nodosa. Arthritis Rheum (1996) 0.82
Epidemiology and clinical consequences of vancomycin-resistant enterococci in liver transplant patients. Transplantation (2001) 0.82
Clinical efficacy of intravenous followed by oral azithromycin monotherapy in hospitalized patients with community-acquired pneumonia. The Azithromycin Intravenous Clinical Trials Group. Antimicrob Agents Chemother (2000) 0.81
Two brothers with p47-phox-deficient chronic granulomatous disease associated with end-stage renal failure. Nephrol Dial Transplant (1995) 0.81
Surface-dependent coagulation enzymes. Flow kinetics of factor Xa generation on live cell membranes. J Biol Chem (2000) 0.80
Prevalence of measles antibodies in hospital personnel. Infect Control (1986) 0.80
Phase II trial of recombinant interleukin-1 beta in patients with metastatic renal cell carcinoma. J Immunother Emphasis Tumor Immunol (1994) 0.80
Escherichia coli sepsis from contaminated platelet transfusion. Arch Intern Med (1986) 0.79
Potential hazards of deionization systems used for water purification in hemodialysis. Artif Organs (1996) 0.79
A single amino acid of the human and rat neurotensin receptors (subtype 1) determining the pharmacological profile of a species-selective neurotensin agonist. Biochem Pharmacol (2000) 0.78
Spread of a toxic-shock syndrome-associated strain of Staphylococcus aureus and measurement of antibodies to staphylococcal enterotoxin F. J Infect Dis (1984) 0.78
Woodfordin D and oenothein A, trimeric hydrolyzable tannins of macro-ring structure with antitumor activity. Chem Pharm Bull (Tokyo) (1991) 0.78
Woodfordin C, a macro-ring hydrolyzable tannin dimer with antitumor activity, and accompanying dimers from Woodfordia fruticosa flowers. Chem Pharm Bull (Tokyo) (1990) 0.78
Isolation and transplantation of highly purified autologous peripheral CD34+ progenitor cells: purging efficacy, hematopoietic reconstitution in non-Hodgkin's lymphoma (NHL): results of Japanese phase II study. Bone Marrow Transplant (2005) 0.78
Adoptive immunotherapy mediated by anti-TCR/IL-2-activated tumour-draining lymph node cells. Immunology (1994) 0.77
Intrarectal hyperthermia of circumferential rectal cancer. Report of 2 cases. Radiat Med (1985) 0.77
The mechanism of ageing of phosphonylated acetylcholinesterase. Eur J Biochem (1979) 0.77
Pulmonary embolism: accuracy and safety of a negative CT pulmonary angiogram and value of a negative D-dimer assay to exclude CT pulmonary angiogram-detectable pulmonary embolism. Australas Radiol (2006) 0.77
Aspirin, hyperventilation, and cerebellar infarction in sickle cell disease. Arch Intern Med (1978) 0.76
Identification of drug-resistant myeloid leukemic cells by measurement of DNA content, nuclear area, and detection of P-glycoprotein. Cancer (1996) 0.75
Maintaining confidentiality in a look-back investigation of patients treated by a HIV-infected dentist. Public Health Rep (1993) 0.75
Disseminated Mycobacterium avium-intracellulare infection in a patient with myelodysplastic syndrome (refractory anemia). Am J Hematol (1994) 0.75
Safety of refrigerated storage of admixed parenteral fluids. J Clin Microbiol (1988) 0.75
Echinococcal infection in a Ghanaian patient. Lancet (1992) 0.75
Proportion of blasts with a clear halo around nucleoli at the end of induction therapy of acute myeloid leukemia correlates with achievement of complete remission, remission duration and relapse. Pathol Int (1998) 0.75
Transplacental immunity to varicella-zoster virus in extremely low birthweight infants. Am J Perinatol (1992) 0.75
Camelliin B and nobotanin I, macrocyclic ellagitannin dimers and related dimers, and their antitumor activity. Chem Pharm Bull (Tokyo) (1989) 0.75
Progression of Wenckebach type A-V block to high degree A-V block in aged man. Tohoku J Exp Med (1983) 0.75
Overexpression of heat shock protein 60 and the survival of blast in acute myeloid leukemia after induction therapy. Leukemia (2000) 0.75
Synergistic effects of cyclosporin analogs--A, D, G, IMM-125--with rapamycin and/or brequinar. Transplant Proc (1994) 0.75
[A multicenter early phase II study of high-dose chemotherapy with autologous peripheral blood stem cell transplantation for treatment of intermediate-grade non-Hodgkin's lymphoma. Japan Blood Cell Transplantation Study Group]. Rinsho Ketsueki (1999) 0.75
P-nitrophenyl phosphate as substrate for rabbit liver fructose diphosphatase. Biochem Biophys Res Commun (1971) 0.75
Analysis of binding sites and efficacy of a species-specific peptide at rat and human neurotensin receptors. J Pept Res (2000) 0.75
[Effect of the interaction of tannins with coexisting substances. VIII. Inhibitory effect of tannins on discoloration of natural pigments]. Yakugaku Zasshi (1995) 0.75
Role of sialyltransferase in hypercupraemia of non-Hodgkin's lymphoma. Scand J Haematol (1984) 0.75
Paroxysmal inflammatory filariasis. Filarial fevers. Arch Intern Med (1983) 0.75
An approach for the generation of effector lymphocytes from tumor-bearing hosts for the adoptive immunotherapy of established tumors. Prog Clin Biol Res (1987) 0.75
[The development process in American nursing]. Sogo Kango (1992) 0.75
[Studies on antibilharzial drugs. Synthesis of substituted-(4-amino-1-naphthylazo)benzenes and substituted-[4-(diethylaminoethylamino)-1-naphthylazo]benzenes]. Yao Xue Xue Bao (1966) 0.75
Detection of circulating tumor cells in a patient with intravascular lymphomatosis: a case study examined by the cytology method. Pathol Int (1998) 0.75
[Ancient dentistry in China] (Jpn). Nihon Ishigaku Zasshi (1980) 0.75
Utility of blasts with a clear halo around the nucleolus as a predictive indicator for disease progression in patients with myelodysplastic syndromes and aplastic anemia. Diagn Cytopathol (2000) 0.75
[Nursing research in the United States]. Sogo Kango (1993) 0.75
A dose-finding study of lenograstim (glycosylated rHuG-CSF) for peripheral blood stem cell mobilization during postoperative adjuvant chemotherapy in patients with breast cancer. Lenograstim/Breast Cancer Study Group. Jpn J Clin Oncol (1999) 0.75
Treatment of advanced primary lung cancer associated with malignant pleural effusion by the combination of immunotherapy and chemotherapy. Oncology (1994) 0.75